Cogent Biosciences, Inc. (COGT)
38.93
-1.37
(-3.40%)
USD |
NASDAQ |
Dec 09, 10:47
Cogent Biosciences Total Liabilities (Quarterly): 123.47M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Pfizer Inc. | 115.64B |
| Ionis Pharmaceuticals, Inc. | 2.415B |
| ADMA Biologics, Inc. | 137.50M |
| Editas Medicine, Inc. | 188.30M |
| AnaptysBio, Inc. | 382.51M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 425.93M |
| Shareholders Equity (Quarterly) | 302.46M |
| Debt to Equity Ratio | 0.2002 |
| Current Ratio | 6.382 |
| Net Debt Paydown Yield | -0.42% |